|1.||Wong, Chi-Huey: 10 articles (03/2015 - 01/2006)|
|2.||Wu, Chung-Yi: 8 articles (12/2014 - 08/2008)|
|3.||Ragupathi, Govind: 6 articles (05/2011 - 10/2003)|
|4.||Hung, Jung-Tung: 5 articles (12/2014 - 08/2008)|
|5.||Yu, Alice L: 5 articles (12/2014 - 08/2008)|
|6.||Danishefsky, Samuel J: 4 articles (03/2015 - 10/2003)|
|7.||Ren, Chien-Tai: 4 articles (12/2014 - 08/2008)|
|8.||Livingston, Philip O: 4 articles (05/2011 - 10/2003)|
|9.||Ragupathi, G: 4 articles (10/2005 - 03/2000)|
|10.||Livingston, P O: 4 articles (10/2005 - 03/2000)|
03/17/2015 - "Development of Globo-H cancer vaccine."
12/01/2014 - "Here, we examine the angiogenic effects of Globo-H ceramide (GHCer), the most prevalent glycolipid in a majority of epithelial cancers and one that acts as an immune checkpoint. "
04/01/2014 - "Similarly, immunohistochemistry showed that Globo H expression was higher in tumors compared to normal tissues. "
03/01/1998 - "Not only did mAb VK-9 react with carbohydrate-protein conjugates but it could also recognize globo H-ceramide and human tumor cells expressing globo H. "
09/26/1997 - "Globo H was present on most cancers of epithelial origin. "
|2.||Breast Neoplasms (Breast Cancer)
03/13/2001 - "Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial."
01/30/2015 - "Quantitative analysis of GSLs revealed both Fuc-LacCer and Globo-H increased in breast cancer tissues. "
12/01/2014 - "Breast cancer cells expressing high levels of GHCer displayed relatively greater tumorigenicity and angiogenesis compared with cells expressing low levels of Globo-H. "
08/19/2008 - "Globo H is a member of this family, which is highly expressed on breast cancer cells. "
08/19/2008 - "Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer."
|3.||Prostatic Neoplasms (Prostate Cancer)
12/03/2014 - "Globo H-based therapeutic cancer vaccines have been tested in clinical trials for the treatment of late stage breast, ovarian, and prostate cancers. "
05/11/1999 - "Globo H is one of several candidate antigens present on prostate cancer cells that can serve as targets for immune recognition and treatment strategies. "
01/01/2001 - "Examples are STn for suppression of breast cancer, GM2 and GD3 for melanoma, and globo-H for prostate cancer. "
03/01/2002 - "Biosynthesis of the carbohydrate antigenic determinants, Globo H, blood group H, and Lewis b: a role for prostate cancer cell alpha1,2-L-fucosyltransferase."
05/11/1999 - "The complex carbohydrate molecule globo H hexasaccharide has been synthesized, conjugated to keyhole limpet hemocyanin, and administered with the immunologic adjuvant QS-21 as a vaccine for patients with prostate cancer who have relapsed after primary therapies such as radiation or surgery. "
|4.||Small Cell Lung Carcinoma (Small Cell Lung Cancer)
|5.||Neuroectodermal Tumors (Neuroectodermal Tumor)
01/01/2001 - "Well-documented examples of such TACAs are: (i) H/Le(y)/Le(a) in primary non-small cell lung carcinoma; (ii) sialyl-Le(x) (SLe(x)) and sialyl-Le(a) (SLe(a)) in various types of cancer; (iii) Tn and sialyl-Tn in colorectal, lung, breast, and many other cancers; (iv) GM2, GD2, and GD3 gangliosides in neuroectodermal tumors (melanoma and neuroblastoma); (v) globo-H in breast, ovarian, and prostate cancer; (vi) disialylgalactosylgloboside in renal cell carcinoma. "
|6.||Human beta Subunit Chorionic Gonadotropin
|7.||Chorionic Gonadotropin (Human Chorionic Gonadotropin)